<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>FcgammaRIIB, a low affinity receptor for the Fc portion of immunoglobulin G (IgG), is thought to drive negative selection of B cells in germinal centers (GC) by inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> upon interaction with immune complexes </plain></SENT>
<SENT sid="1" pm="."><plain>Its expression was investigated by immunohistochemistry in 22 reactive lymphoid tissues and 112 B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Pre-GC mantle cells, marginal zone cells and their neoplastic counterparts expressed FcgammaRIIB </plain></SENT>
<SENT sid="3" pm="."><plain>The B <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (B-CLL)/small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were also positive </plain></SENT>
<SENT sid="4" pm="."><plain>Not detected in GC, FcgammaRIIB was expressed in 52% of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and in 20% of diffuse large B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, FcgammaRIIB expression was linked to transformation (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Re-analysis of a gene profile data set from the Lymphochip microarrays showed that FcgammaRIIB expression in the activated B-like <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> subgroup was higher than in the GC-like one (P &lt; 0.04), and was associated with an adverse prognostic both in univariate (P &lt; 0.003) and in multivariate analysis including the International Prognostic Indicator (IPI) (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Thus these results challenge the potential role of FcgammaRIIB during B-cell selection in GC, and suggest a prognostic value of FcgammaRIIB expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
</text></document>